Follow-up of Patients After Knee Arthrodesis With an Intramedullary Nail

This study is currently recruiting participants.

Verified August 2011 by University Hospital, Ghent

First Received on January 30, 2006. Last Updated on August 5, 2011 History of Changes

Sponsor:	University Hospital, Ghent
Information provided by:	University Hospital, Ghent
ClinicalTrials.gov Identifier:	NCT00284297

Purpose

Follow-up of patients who underwent a knee arthrodesis with different types of intramedullary nails.

Condition	Intervention
Knee Arthrodesis With Intramedullary Nail	Procedure: History taken and clinical examination

Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	Follow-up of Patients After Knee Arthrodesis With an Intramedullary Nail

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:

Follow-up of patients who underwent a knee arthrodesis with different types of intramedullary nails [ Designated as safety issue: Yes ]

Estimated Enrollment:	20
Study Start Date:	September 2005
Estimated Study Completion Date:	August 2011
Estimated Primary Completion Date:	August 2011 (Final data collection date for primary outcome measure)

Intervention Details:

History is taken and clinical examination is followed

Eligibility

Criteria

Inclusion Criteria:

All patients who underwent a knee arthrodesis with an intramedullary nail between 1994 and 2005

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00284297

Contacts

Contact: René Verdonk, MD, PhD

+ 32 9 332.22.48

Locations

Belgium
University Hospital Ghent	Recruiting
Ghent, Belgium, 9000
Contact: René Verdonk, MD, PhD + 32 9 332.22.48 rene.verdonk@ugent.be
Principal Investigator: René Verdonk, MD, PhD

Sponsors and Collaborators

University Hospital, Ghent

Investigators

Principal Investigator:

René Verdonk, MD, PhD

University Hospital, Ghent

More Information

Additional Information:

Website University Hospital Ghent This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party:	Rene Verdonk, University Hospital Ghent
ClinicalTrials.gov Identifier:	NCT00284297 History of Changes
Other Study ID Numbers:	2005/213
Study First Received:	January 30, 2006
Last Updated:	August 5, 2011
Health Authority:	Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on February 09, 2012